Form D · Biotechnology
StrataBio Inc.
Tallahassee, FL · CIK 0002150600
Offering snapshot reported Aug 31, 2026 · SEC filing
- Reported sold
- $25K Offering amount: $500K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Aug 27, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 31, 2026 | Initial | $25,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-595978
Source: Form D, filed Aug 31, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Tom Chepucavage | Executive |
| Andrew Leon De Luise | Director, Executive, Promoter |
| Anthony Franklin | Executive |
| Michael Kramer | Director, Executive, Promoter |
| Robert French Long | Director, Executive, Promoter |
| Corey Park | Promoter |
| Sophia Tremari Lombardo | Director, Promoter |
| Scott Warden | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5583 Tower Woods Trl
Tallahassee, FL, 32303
Phone: 4784615488
Tallahassee, FL, 32303
Phone: 4784615488